table of content
1 Study Coverage
1.1 Blood-Brain Barrier Transport Drugs Product Introduction
1.2 Global Blood-Brain Barrier Transport Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Blood-Brain Barrier Transport Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Blood-Brain Barrier Transport Drugs Sales in Volume for the Year 2017-2028
1.3 United States Blood-Brain Barrier Transport Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Blood-Brain Barrier Transport Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Blood-Brain Barrier Transport Drugs Sales in Volume for the Year 2017-2028
1.4 Blood-Brain Barrier Transport Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Blood-Brain Barrier Transport Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Blood-Brain Barrier Transport Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Blood-Brain Barrier Transport Drugs Market Dynamics
1.5.1 Blood-Brain Barrier Transport Drugs Industry Trends
1.5.2 Blood-Brain Barrier Transport Drugs Market Drivers
1.5.3 Blood-Brain Barrier Transport Drugs Market Challenges
1.5.4 Blood-Brain Barrier Transport Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Blood-Brain Barrier Transport Drugs Market Segment by Type
2.1.1 Carrier-mediated Transport
2.1.2 Receptor-mediated Transport
2.1.3 Absorptive-mediated Transport
2.1.4 Active Efflux Transport
2.1.5 Others
2.2 Global Blood-Brain Barrier Transport Drugs Market Size by Type
2.2.1 Global Blood-Brain Barrier Transport Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Blood-Brain Barrier Transport Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Blood-Brain Barrier Transport Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Blood-Brain Barrier Transport Drugs Market Size by Type
2.3.1 United States Blood-Brain Barrier Transport Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Blood-Brain Barrier Transport Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Blood-Brain Barrier Transport Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Blood-Brain Barrier Transport Drugs Market Segment by Application
3.1.1 Alzheimer's Disease
3.1.2 Epilepsy
3.1.3 Parkinson's Disease
3.1.4 Multiple Sclerosis
3.1.5 Hunter's Syndrome
3.1.6 Brain Cancer
3.1.7 Others
3.2 Global Blood-Brain Barrier Transport Drugs Market Size by Application
3.2.1 Global Blood-Brain Barrier Transport Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Blood-Brain Barrier Transport Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Blood-Brain Barrier Transport Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Blood-Brain Barrier Transport Drugs Market Size by Application
3.3.1 United States Blood-Brain Barrier Transport Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Blood-Brain Barrier Transport Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Blood-Brain Barrier Transport Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Blood-Brain Barrier Transport Drugs Competitor Landscape by Company
4.1 Global Blood-Brain Barrier Transport Drugs Market Size by Company
4.1.1 Top Global Blood-Brain Barrier Transport Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Blood-Brain Barrier Transport Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Blood-Brain Barrier Transport Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Blood-Brain Barrier Transport Drugs Price by Manufacturer (2017-2022)
4.2 Global Blood-Brain Barrier Transport Drugs Concentration Ratio (CR)
4.2.1 Blood-Brain Barrier Transport Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Blood-Brain Barrier Transport Drugs in 2021
4.2.3 Global Blood-Brain Barrier Transport Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Blood-Brain Barrier Transport Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Blood-Brain Barrier Transport Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Blood-Brain Barrier Transport Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Blood-Brain Barrier Transport Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Blood-Brain Barrier Transport Drugs Market Size by Company
4.5.1 Top Blood-Brain Barrier Transport Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Blood-Brain Barrier Transport Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Blood-Brain Barrier Transport Drugs Sales by Players (2020, 2021 & 2022)
5 Global Blood-Brain Barrier Transport Drugs Market Size by Region
5.1 Global Blood-Brain Barrier Transport Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Blood-Brain Barrier Transport Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Blood-Brain Barrier Transport Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Blood-Brain Barrier Transport Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Blood-Brain Barrier Transport Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Blood-Brain Barrier Transport Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Blood-Brain Barrier Transport Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Blood-Brain Barrier Transport Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Blood-Brain Barrier Transport Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Blood-Brain Barrier Transport Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Blood-Brain Barrier Transport Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Blood-Brain Barrier Transport Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Blood-Brain Barrier Transport Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Blood-Brain Barrier Transport Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Blood-Brain Barrier Transport Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Blood-Brain Barrier Transport Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Blood-Brain Barrier Transport Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Cyclenium
7.1.1 Cyclenium Corporation Information
7.1.2 Cyclenium Description and Business Overview
7.1.3 Cyclenium Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Cyclenium Blood-Brain Barrier Transport Drugs Products Offered
7.1.5 Cyclenium Recent Development
7.2 BioAdvance
7.2.1 BioAdvance Corporation Information
7.2.2 BioAdvance Description and Business Overview
7.2.3 BioAdvance Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 BioAdvance Blood-Brain Barrier Transport Drugs Products Offered
7.2.5 BioAdvance Recent Development
7.3 EIP Pharma
7.3.1 EIP Pharma Corporation Information
7.3.2 EIP Pharma Description and Business Overview
7.3.3 EIP Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 EIP Pharma Blood-Brain Barrier Transport Drugs Products Offered
7.3.5 EIP Pharma Recent Development
7.4 Bioasis
7.4.1 Bioasis Corporation Information
7.4.2 Bioasis Description and Business Overview
7.4.3 Bioasis Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Bioasis Blood-Brain Barrier Transport Drugs Products Offered
7.4.5 Bioasis Recent Development
7.5 Immune Pharmaceuticals
7.5.1 Immune Pharmaceuticals Corporation Information
7.5.2 Immune Pharmaceuticals Description and Business Overview
7.5.3 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Products Offered
7.5.5 Immune Pharmaceuticals Recent Development
7.6 AZ Therapies
7.6.1 AZ Therapies Corporation Information
7.6.2 AZ Therapies Description and Business Overview
7.6.3 AZ Therapies Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 AZ Therapies Blood-Brain Barrier Transport Drugs Products Offered
7.6.5 AZ Therapies Recent Development
7.7 Palobiofarma
7.7.1 Palobiofarma Corporation Information
7.7.2 Palobiofarma Description and Business Overview
7.7.3 Palobiofarma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Palobiofarma Blood-Brain Barrier Transport Drugs Products Offered
7.7.5 Palobiofarma Recent Development
7.8 Bach Pharma
7.8.1 Bach Pharma Corporation Information
7.8.2 Bach Pharma Description and Business Overview
7.8.3 Bach Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Bach Pharma Blood-Brain Barrier Transport Drugs Products Offered
7.8.5 Bach Pharma Recent Development
7.9 BrainsGate
7.9.1 BrainsGate Corporation Information
7.9.2 BrainsGate Description and Business Overview
7.9.3 BrainsGate Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 BrainsGate Blood-Brain Barrier Transport Drugs Products Offered
7.9.5 BrainsGate Recent Development
7.10 CarThera
7.10.1 CarThera Corporation Information
7.10.2 CarThera Description and Business Overview
7.10.3 CarThera Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 CarThera Blood-Brain Barrier Transport Drugs Products Offered
7.10.5 CarThera Recent Development
7.11 Dainippon Sumitomo Pharma
7.11.1 Dainippon Sumitomo Pharma Corporation Information
7.11.2 Dainippon Sumitomo Pharma Description and Business Overview
7.11.3 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Products Offered
7.11.5 Dainippon Sumitomo Pharma Recent Development
7.12 Fluorinov Pharma
7.12.1 Fluorinov Pharma Corporation Information
7.12.2 Fluorinov Pharma Description and Business Overview
7.12.3 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Fluorinov Pharma Products Offered
7.12.5 Fluorinov Pharma Recent Development
7.13 Fondazione Telethon
7.13.1 Fondazione Telethon Corporation Information
7.13.2 Fondazione Telethon Description and Business Overview
7.13.3 Fondazione Telethon Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Fondazione Telethon Products Offered
7.13.5 Fondazione Telethon Recent Development
7.14 Minoryx
7.14.1 Minoryx Corporation Information
7.14.2 Minoryx Description and Business Overview
7.14.3 Minoryx Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Minoryx Products Offered
7.14.5 Minoryx Recent Development
7.15 NewGen Therapeutics
7.15.1 NewGen Therapeutics Corporation Information
7.15.2 NewGen Therapeutics Description and Business Overview
7.15.3 NewGen Therapeutics Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 NewGen Therapeutics Products Offered
7.15.5 NewGen Therapeutics Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Blood-Brain Barrier Transport Drugs Industry Chain Analysis
8.2 Blood-Brain Barrier Transport Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Blood-Brain Barrier Transport Drugs Distributors
8.3 Blood-Brain Barrier Transport Drugs Production Mode & Process
8.4 Blood-Brain Barrier Transport Drugs Sales and Marketing
8.4.1 Blood-Brain Barrier Transport Drugs Sales Channels
8.4.2 Blood-Brain Barrier Transport Drugs Distributors
8.5 Blood-Brain Barrier Transport Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
